|
Shogenova M.S., Khutueva S.Kh., Shogenova L.S.
Peculiarities of multi-component subscutaneous allergen-specific immunotherapy with weed allergens performing
|
№2 / 2024
|
|
Pozdnyakova O.Yu., Dyshekova N.V., Dokhkaeva A.Z.
Peculiarities of food sensitization in patients having bronchial asthma in combinationwith Helicobacter pylori-associated chronic gastritis
|
№2 / 2024
|
|
Budnevsky A.V., Tribuntseva L.V., Chernik T.A., Ivanchuk Yu.S., Kravchenko A.Ya.
Impact of osteoarthritis on the asthma clinical course: Focus on physical activity and quality of life
|
№2 / 2024
|
|
Anikin D.A., Solovieva I.A., Demko I.V., Sobko E.A., Gordeeva N.V., Kraposhina A.Yu.
Peculiarities of the association of bronchial asthma with obesity depending on the time of asthma debut and the possibilities of cardiovascular risk prediction in this group of patients
|
№10 / 2022
|
|
Babak S.L., Gorbunova M.V., Goruleva E.I., Malyavin A.G.
Clinical life hacks in the treatment of acute bronchitis in post-covid patients with a new generation of phytodrugs BNO1201/1205
|
№7 / 2022
|
|
Prozorova G.G., Fateeva O.V., Tribuntseva L.V., Kozhevnikova S.A., Olysheva I.A.
Non-drug methods of treatment in pulmonology
|
№6 / 2022
|
|
Starodubtseva I.A., Lesina V.S., Kostina N.E., Venderevskaya K.V.
Bronchial asthma and cardiovascular comorbidity: interconnections and approaches to therapy
|
№5 / 2022
|
|
Babak S.L., Gorbunova M.V., Goruleva E.I., Malyavin A.G.
Nebulized budesonide in asthma exacerbations: rules of therapy in the COVID-19 era
|
№5 / 2022
|
|
Babak S.L., Gorbunova M.V., Malyavin A.G.
Mucins and carbocisteine: respiratory protection
|
№10 / 2021
|
|
Averyanov A.B., Cherkashina I.I., Nikulina S.Yu., Maksimov V.N.
Analysis of polymorphism rs6737848 of SOCS5 gene with bronchial asthma
|
№9 / 2021
|
|
Baranov D.Z., Trofimov V.I., Lapin S.V., Mazing A.V., Kholopova I.V., Kuznetsova D.A., Moshnikova A.N., Blinova T.V.
Evaluation of periostin in case of bronchoostructive diseases
|
№8 / 2021
|
|
Babak S.L., Gorbunova M.V., Malyavin A.G.
Strategy of mucolytic therapy: ambroxol
|
№1 / 2021
|
Русский
